• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16732 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for fetal growth and volume measurements
2005     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of Bortezomib (Velcade®) within NHS Wales
2005     WorkSafeBC Alternative medicine: some definitions, evidence & references for health care benefits guidelines
2005     Adelaide Health Technology Assessment (AHTA) Digital mammography: a screening modality for breast cancer
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for high-risk pregnancies and routine screening
2005     Health Council of the Netherlands Gezondheidsraad (GR) Use of antiviral agents and other measures in an influenza pandemic
2005     NIHR Health Technology Assessment programme The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis
2005     WorkSafeBC Artificial cervical and lumbar disc implants: a review of the literature
2005     Adelaide Health Technology Assessment (AHTA) TomoTherapy HI-ART System(R): radiotherapy planning and treatment for cancer patients
2005     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Endokeratoplasty for decompensated corneal endothelium
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Glycoprotein IIb/IIIa antagonists: a systematic review of randomized clinical trials in patients undergoing percutaneous coronary intervention
2005     Andalusian Health Technology Assessment Area (AETSA) Bevacizumab in the treatment of advanced colon cancer- review
2005     NIHR Health Technology Assessment programme Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials
2005     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Proposal for criteria of public coverage and prioritisation in assisted human reproduction
2005     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Injectable silicone biomaterial implants
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women: a systematic review of efficacy and safety evidence
2005     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review
2005     Medical Advisory Secretariat (MAS) Technologies for osteoarthritis of the knee: an evidence-based analysis
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Botulinum toxin A for upper and lower limb spasticity: a systematic review
2005     Andalusian Health Technology Assessment Area (AETSA) Genetic Testing assessment framework in the Andalusian Public Health System - guidelines
2005     NIHR Health Technology Assessment programme A trial of problem-solving by community mental health nurses for anxiety, depression and life difficulties among general practice patients. The CPN-GP study
2004     Quality Improvement Scotland (NHS QIS ) Newer drugs for epilepsy in adults
2004     Quality Improvement Scotland (NHS QIS ) The use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia
2004     Quality Improvement Scotland (NHS QIS ) Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding
2004     ECRI Angiogenesis therapy for intractable ischemic heart disease
2004     Quality Improvement Scotland (NHS QIS ) Newer drugs for epilepsy in children
2004     ECRI Autologous chondrocyte implantation for knee cartilage defects
2004     Quality Improvement Scotland (NHS QIS ) Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome
2004     NIHR Horizon Scanning Centre (NIHR HSC) Rituximab for 1st line low-grade non-Hodgkin's lymphoma - horizon scanning review
2004     Quality Improvement Scotland (NHS QIS ) Frequency of application of topical corticosteroids for atopic eczema
2004     NIHR Horizon Scanning Centre (NIHR HSC) Docetaxel as adjuvant therapy in early stage breast cancer - horizon scanning review
2004     Quality Improvement Scotland (NHS QIS ) Tacrolimus and pimecrolimus for atopic eczema
2004     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for first-line treatment of metastatic colorectal cancer - horizon scanning review
2004     Quality Improvement Scotland (NHS QIS ) Laparoscopic surgery for inguinal hernia repair (review)
2004     NIHR Horizon Scanning Centre (NIHR HSC) Breath test for lung cancer screening - horizon scanning review
2004     Quality Improvement Scotland (NHS QIS ) Drotrecogin alfa (activated) for severe sepsis
2004     NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel as adjuvant therapy in early stage breast cancer - horizon scanning review
2004     HAYES, Inc. Percutaneous alcohol ablation for palliative treatment of pain
2004     Quality Improvement Scotland (NHS QIS ) Immunosuppressive therapy for renal transplantation in adults
2004     NIHR Horizon Scanning Centre (NIHR HSC) FibroTest-ActiTest, a diagnostic test for liver fibrosis in patients with hepatitis C - horizon scanning review
2004     HAYES, Inc. Percutaneous vertebroplasty and kyphoplasty
2004     Quality Improvement Scotland (NHS QIS ) Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours
2004     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Are tailor-made drugs just around the corner? Abridged version of the TA-SWISS study 'Pharmacogenetics and Pharmacogenomics'
2004     HAYES, Inc. Photodynamic therapy for actinic keratoses
2004     Quality Improvement Scotland (NHS QIS ) Comparison of digital mammography and film screen mammography
2004     Quality Improvement Scotland (NHS QIS ) Treatments for opiate dependence
2004     NIHR Horizon Scanning Centre (NIHR HSC) Sildenafil citrate for adult pulmonary arterial hypertension - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Bivalirudin for percutaneous coronary interventions (PCI) - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Sacrosidase (Sucraid) for congenital sucrase-isomaltase deficiency - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Nitisinone for hereditary tyrosinaemia type 1 (HT-1) - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Miglustat for type 3 Gaucher's, Niemann-Pick type C and lateonset Tay-Sachs disease - horizon scanning review [withdrawn]
2004     Agency for Healthcare Research and Quality (AHRQ) Screening for bladder cancer
2004     NIHR Horizon Scanning Centre (NIHR HSC) StaphVAX for the prevention of Staphylococcus aureus infections in end stage renal disease - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Cinacalcet HCl for secondary hyperparathyroidism - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast for asthma and chronic obstructive pulmonary disease - horizon scanning review
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Cinacalcet for secondary hyperparathyroidism
2004     NIHR Horizon Scanning Centre (NIHR HSC) Infliximab for psoriasis - horizon scanning review
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Duloxetine for major depressive disorder and stress urinary incontinence
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Insulin glargine for type 2 diabetes
2004     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Assessment of photodynamic therapy using porfimer sodium for esophageal, bladder and lung cancers
2004     HAYES, Inc. Positron emission tomography (PET) for Huntington's disease (HD)
2004     Agency for Healthcare Research and Quality (AHRQ) Measuring the quality of breast cancer care in women
2004     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Home-based chemotherapy for cancer: issues for patients, caregivers and the health care system
2004     Agency for Healthcare Research and Quality (AHRQ) Training of hospital staff to respond to a mass casualty incident
2004     VA Technology Assessment Program (VATAP) Surgical robotics
2004     Agency for Healthcare Research and Quality (AHRQ) Pharmacological and surgical treatment of obesity
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Nitric oxide measurement system (NIOX) for monitoring response to asthma treatment
2004     VA Technology Assessment Program (VATAP) Outcome measurement in major depression (Number 3 in a Series: Outcome measurement in VHA mental health services)
2004     New Zealand Health Technology Assessment (NZHTA) What is the evidence for the effectiveness of managing the hospital/community interface for older people? A critical appraisal of the literature
2004     New Zealand Health Technology Assessment (NZHTA) Evidence based review of medicines for sexual dysfunction in men: a report commissioned by the New Zealand Accident Compensation Corporation (ACC)
2004     New Zealand Health Technology Assessment (NZHTA) Evidence based review of medicines for sexual dysfunction in females: a report commissioned by the New Zealand Accident Compensation Corporation (ACC)
2004     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004     NIHR Health Technology Assessment programme What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
2004     NIHR Health Technology Assessment programme Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation
2004     HAYES, Inc. Positron emission tomography (PET) for Parkinson's disease
2004     NIHR Health Technology Assessment programme Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation
2004     NIHR Health Technology Assessment programme Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Cryotherapy for prostate cancer
2004     NIHR Health Technology Assessment programme Methods for identifying and classifying surgical site infection after discharge from hospital
2004     Finnish Office for Health Care Technology Assessment (Finohta) [Screening for rare metabolic disease in newborn infants]
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Quantitative approaches to patient safety. Research in risk analysis and risk management as applied to radiotherapy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Diabetic testing
2004     Alberta Heritage Foundation for Medical Research (AHFMR) A selected inventory of abstracts of Cochrane reviews on physiotherapy/physical therapy - interim report for expert advisory panel and the research team
2004     New Zealand Health Technology Assessment (NZHTA) What is the evidence for the effectiveness of behavioural and skill-based early intervention in young children with autism spectrum disorder (ASD)?
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) EMDR for treatment of post-traumatic stress disorder
2004     NIHR Health Technology Assessment programme Involving South Asian patients in clinical trials
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Endometrial ablation for menorrhagia
2004     NIHR Health Technology Assessment programme The value of a QALY implied by the value of a 'statistical life' in the field of transport
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Interventional and intraoperative magnetic resonance imaging
2004     HAYES, Inc. Postoperative disposable ambulatory regional anesthesia
2004     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Insulin pen-fill formulations
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Profile of an HTA program: the AHFMR Health Technology Assessment Unit, 2002-2003
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Patient lift technologies
2004     Malaysian Health Technology Assessment Unit (MHTAU) Misoprostol in pregnancy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Prolotherapy for the treatment of chronic musculoskeletal pain
2004     Malaysian Health Technology Assessment Unit (MHTAU) Screening for hearing loss in infants
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Thalidomide for the treatment of multiple myeloma
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for hearing loss in high risk babies
2004     Malaysian Health Technology Assessment Unit (MHTAU) Second generation endometrial ablation